The Microdose

DEA charging thousands for Right To Try documents, a manifesto for psychonauts, and another one bites the dust

Links between PTSD and hallucinogens, psychedelic investing beyond pharmaceuticals, and supporting survivors

Let old folks trip, patenting a psychedelic patch, and what do psychedelics and near-death experiences have in common?

The psychedelic hype cycle, MindMed co-founder sues fellow co-founder, and patenting toad secretions

Psychedelics for alcoholism, another withdrawal from DEA, and Terran sues Compass

People’s expectations influence microdosing outcomes, Canadians sue government for psilocybin access, and a post-mortem on the DEA’s canceled tryptamine ban

DEA abandons plan to prohibit more psychedelics, Colorado to vote on psychedelics in November, APA says science to support psychedelic treatment is “inadequate”